SP-MHCI-0499-2

Human RSV Nucleoprotein 306-314, NPKASLLSL

US$169.00

In stock

Description

About Human RSV Nucleoprotein 306-314, NPKASLLSL

The Respiratory Syncytial Virus (RSV) Nucleoprotein Peptide (IEDB: 45374) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Nucleoprotein Peptide, H-NPKASLLSL-OH (Uniprot: O42053 aa: 306-314) from JPT is produced under strict quality control and quality management.

Human RSV Nucleoprotein 306-314, NPKASLLSL - Specifications

  • Peptide sequence: H-NPKASLLSL-OH
  • Amount: 1 mg
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Respiratory infection
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Peptide Synthesis Services!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Human RSV Nucleoprotein 306-314, NPKASLLSL

References:
Read References with JPT’s Antigen Peptides
Human RSV Nucleoprotein 306-314, NPKASLLSL has been described in:
Human CD8(+) T cell responses against five newly identified respiratory syncytial virus-derived epitopes., J Gen Virol, 2004 (PMID: 15269378)
Respiratory syncytial virus-specific CD8+ memory T cell responses in elderly persons., J Infect Dis, 2005 (PMID: 15838799)
A Micropolymorphism Altering the Residue Triad 97/114/156 Determines the Relative Levels of Tapasin Independence and Distinct Peptide Profiles for HLA-A(*)24 Allotypes., J Immunol Res, 2014 (PMID: 25802875)

Documentation

Documentation for Human RSV Nucleoprotein 306-314, NPKASLLSL

Properties

Properties of Human RSV Nucleoprotein 306-314, NPKASLLSL

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Respiratory infection
Layout: Freeze-dried in glass vial
Organism: Respiratory Syncytial Virus (RSV)
Protein Name: Nucleoprotein
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to Human RSV Nucleoprotein 306-314, NPKASLLSL

Information Values
Sequence: H-NPKASLLSL-OH
Specifications: 9mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote